SOZO
DeviceThe SOZO device is a bioimpedance spectroscopy device that measures bioimpedance parameters.
NCT Number: NCT02939053
This study aims to establish the degree to which change in the ratio of ECF to TBW measured using the SOZO BIS device correlates with change in end-expiratory end-diastolic PAP measured using the CardioMEMS HF System (St. Jude Medical).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Mayo Clinic, Rochester, Minnesota, United States
This is a prospective, single-arm, observational, non-randomized clinical study that will enroll patients with heart failure who have had a CardioMEMS™ device implanted to monitor their diastolic pulmonary artery pressure. The study will recruit and enroll thirty participants. Participants will be monitored daily at home for a period of 30 days. Each day, the patient's diastolic pulmonary artery pressure will be measured by CardioMEMS™ and the ImpediMed's BIS technology. Participant's weight will also be taken each day.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The SOZO device is a bioimpedance spectroscopy device that measures bioimpedance parameters.
Time frame: From baseline through study completion, an average of 30 days
Changes of body fluid levels in heart failure patients
Time frame: From baseline through study completion, an average of 30 days
Changes of thoracic fluid levels in heart failure patients
Time frame: From baseline through study completion, an average of 30 days
Changes of lower limb fluid levels in heart failure patients
ImpediMed Limited
Industry
Correlation of Bioimpedance Measurements From the SOZO Device With Pulmonary Arterial Pressure Measurements From the CardioMEMS HF System
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01381172
Cardiovascular Diseases, Heart Diseases
Glendale, Arizona, United States
View Trial DetailsNCT02857231
NYHA Class III Heart Failure
La Jolla, California, United States
View Trial DetailsNCT01162707
NYHA Class III Heart Failure
Atlanta, Georgia, United States
View Trial DetailsNCT07574593
Cardiovascular Diseases, Heart Diseases
Chula Vista, California, United States
View Trial Details